CGRP Education & Research Forum
Already a member? Become a member Register
youtubeLinkedIn
Latest:

Videos

Expert views and opinion

International experts discuss hot topics in the prevention of migraine in patients worldwide.

PlayPRODROME results published in The Lancet
PRODROME results published in The Lancet
Play한국의 두통 연구에 관해 몇 가지 말씀해 주시겠습니까?
한국의 두통 연구에 관해 몇 가지 말씀해 주시겠습니까?
Play한국에서의 편두통 치료 개선을 위해 어떤 변화가 도움이 되겠습니까?
한국에서의 편두통 치료 개선을 위해 어떤 변화가 도움이 되겠습니까?
Play편두통 치료법 사용에 관련하여 의사들에게 어떤 조언을 하시겠습니까?
편두통 치료법 사용에 관련하여 의사들에게 어떤 조언을 하시겠습니까?
PlayCan you tell us about some of the headache research in Korea?
Can you tell us about some of the headache research in Korea?
PlayWhat changes would help to improve migraine care in Korea?
What changes would help to improve migraine care in Korea?
PlayWhat advice would you give doctors about using migraine therapies?
What advice would you give doctors about using migraine therapies?
Play한국에서 편두통은 얼마나 흔합니까?
한국에서 편두통은 얼마나 흔합니까?
Play한국에서 편두통 진단은 어떻게 합니까?
한국에서 편두통 진단은 어떻게 합니까?
Play한국에는 어떤 편두통 치료법이 있습니까?
한국에는 어떤 편두통 치료법이 있습니까?
Play항CGRP 치료법은 한국에서의 연구와 임상 진료에서 얼마나 효과가 있었습니까?
항CGRP 치료법은 한국에서의 연구와 임상 진료에서 얼마나 효과가 있었습니까?
PlayHow effective have anti-CGRP therapies been in Korean studies and in clinical practice?
How effective have anti-CGRP therapies been in Korean studies and in clinical practice?
PlayWhich migraine therapies are available in Korea?
Which migraine therapies are available in Korea?
PlayHow is migraine diagnosed in Korea?
How is migraine diagnosed in Korea?
PlayHow common is migraine in Korea
How common is migraine in Korea
PlayWhat advice would you give doctors about using migraine therapies?
What advice would you give doctors about using migraine therapies?
PlayWhat changes are needed to improve migraine care in India?
What changes are needed to improve migraine care in India?
PlayWhat is your experience of using migraine therapies for episodic and chronic migraine and medication overuse headache?
What is your experience of using migraine therapies for episodic and chronic migraine and medication overuse headache?
PlayHow are migraine attacks prevented in India?
How are migraine attacks prevented in India?
PlayHow is acute migraine treated in India?
How is acute migraine treated in India?
PlayWhat are the specific reasons why migraine is under-diagnosed in India?
What are the specific reasons why migraine is under-diagnosed in India?
PlayIs migraine under-diagnosed in India and what are the barriers to diagnosis?
Is migraine under-diagnosed in India and what are the barriers to diagnosis?
PlayWhat are the main triggers for migraine in India?
What are the main triggers for migraine in India?
PlayHow common is migraine in India?
How common is migraine in India?
PlayWhat advice do you give clinicians talking to insurers about reimbursement?
What advice do you give clinicians talking to insurers about reimbursement?
PlayCan clinicians combine anti-CGRP therapies with other treatments?
Can clinicians combine anti-CGRP therapies with other treatments?
Playما هي النصيحة التي تقدمها للأطباء الذين يتحدثون لشركات التأمين حول تسديد تكاليف العلاج؟
ما هي النصيحة التي تقدمها للأطباء الذين يتحدثون لشركات التأمين حول تسديد تكاليف العلاج؟
Playهل يمكن للأطباء الجمع بين العلاجات المضادة لـ CGRP  والعلاجات الأخرى المستخدمة؟
هل يمكن للأطباء الجمع بين العلاجات المضادة لـ CGRP والعلاجات الأخرى المستخدمة؟
PlayHow can clinicians identify suitable patients for anti-CGRP therapies?
How can clinicians identify suitable patients for anti-CGRP therapies?
PlayHow well do patients respond to anti-CGRP therapies?
How well do patients respond to anti-CGRP therapies?
Playكيف يمكن للأطباء تحديد المرضى المناسبين للعلاجات المضادة لـ CGRP؟
كيف يمكن للأطباء تحديد المرضى المناسبين للعلاجات المضادة لـ CGRP؟
Playما مدى استجابة المرضى للعلاجات المضادة لـ CGRP؟
ما مدى استجابة المرضى للعلاجات المضادة لـ CGRP؟
PlayIn the Middle East, how common is migraine and what medicines are used?
In the Middle East, how common is migraine and what medicines are used?
PlayWhat are the main treatment problems and how can these be addressed?
What are the main treatment problems and how can these be addressed?
Playما مدى انتشار الصداع النصفي (الشقيقة) في الشرق الأوسط وما هي الأدوية المستخدمة؟
ما مدى انتشار الصداع النصفي (الشقيقة) في الشرق الأوسط وما هي الأدوية المستخدمة؟
Playما هي المشاكل الرئيسية في العلاج وكيف يمكن التعامل معها؟
ما هي المشاكل الرئيسية في العلاج وكيف يمكن التعامل معها؟
PlayWhat advice would you give clinicians about how patients can obtain reimbursement for anti-CGRP therapies?
What advice would you give clinicians about how patients can obtain reimbursement for anti-CGRP therapies?
PlayQue conselhos daria aos médicos para ajudar os pacientes a obter o reembolso de terapias anti-CGRP?
Que conselhos daria aos médicos para ajudar os pacientes a obter o reembolso de terapias anti-CGRP?
PlayO que os médicos devem saber sobre a combinação de terapias anti-CGRP com outros tratamentos para a migrânea?
O que os médicos devem saber sobre a combinação de terapias anti-CGRP com outros tratamentos para a migrânea?
PlayWhat should clinicians know about combining anti-CGRP therapies with other migraine treatments?
What should clinicians know about combining anti-CGRP therapies with other migraine treatments?
PlayQuais pacientes podem se beneficiar das terapias anti-CGRP e como é o acompanhamento de terapias anti-CGRP?
Quais pacientes podem se beneficiar das terapias anti-CGRP e como é o acompanhamento de terapias anti-CGRP?
PlayWhich patients in Brazil are suitable for anti-CGRP therapies and how do you follow up people on anti-CGRP therapies?
Which patients in Brazil are suitable for anti-CGRP therapies and how do you follow up people on anti-CGRP therapies?
PlayQuão boas são as evidências apoiando as terapias anti-CGRP?
Quão boas são as evidências apoiando as terapias anti-CGRP?
PlayQuais são os principais problemas enfrentados pelos médicos que tratam a migrânea no Brasil?
Quais são os principais problemas enfrentados pelos médicos que tratam a migrânea no Brasil?
PlayQuão comum é a migrânea no Brasil e como ela é tratada
Quão comum é a migrânea no Brasil e como ela é tratada
PlayHow good is the evidence supporting anti-CGRP therapies?
How good is the evidence supporting anti-CGRP therapies?
PlayWhat are the main problems for doctors treating migraine in Brazil?
What are the main problems for doctors treating migraine in Brazil?
PlayHow common is migraine in Brazil and how is it treated?
How common is migraine in Brazil and how is it treated?
PlayCombining CGRP mAbs and gepants: what do we know?
Combining CGRP mAbs and gepants: what do we know?
Play2020 brought new hope for patients with migraine – how will 2021 build on this success?
2020 brought new hope for patients with migraine – how will 2021 build on this success?
PlayAnti-CGRP therapies – what did we learn in 2020 and what can we expect in 2021?
Anti-CGRP therapies – what did we learn in 2020 and what can we expect in 2021?
PlayMigraine: a new treatment landscape
Migraine: a new treatment landscape
PlayCGRP in cluster headache
CGRP in cluster headache
PlayCGRP therapies in acute migraine
CGRP therapies in acute migraine
PlayWhat next for anti-CGRP therapy?
What next for anti-CGRP therapy?
PlayBecome a member of CGRP Forum
Become a member of CGRP Forum
PlayWhy is CGRP an important therapeutic target?
Why is CGRP an important therapeutic target?

The opinions and statements made in videos and interviews are those of the contributors. The grantors, editors, editorial board or Secretariat do not necessarily share the views expressed. No liability on the part of the grantors, editors, editorial board or Secretariat is accepted for the consequences of any misleading or inaccurate information.